Connect with us

European Investment Bank

InvestEU: €10 million support by the European Investment Bank to allow the scale-up of cancer detection technology in Poland

SHARE:

Published

3 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The European Investment Bank (EIB) has signed an agreement for a loan of up to €10 million with Lublin-based Polish company SDS Optic Inc., to support the development and commercialisation of its diagnostic and monitoring photonic biosensing platform. It is designed specifically to speed up cancer diagnostic time and increase precision and effects of advanced cancer treatments. The EIB investment is backed by the InvestEU programme.

SDS Optic Inc. develops, produces, and commercialises diagnostics and monitoring devices, with a focus on assisting healthcare providers with faster, less painful diagnostics and targeted treatment procedures. The company merges molecular biology, advanced photonic technologies, immunochemistry, and biomedical engineering, having developed the first ever single cell resolution immunoassay for breast cancer real-time diagnostic.

Economy Commissioner Paolo Gentiloni said: “With this investment backed by the InvestEU programme, we double down on our commitment to improve the quality of life for people affected by cancer. This agreement not only highlights our dedication to advance healthcare innovation but also strengthens Europe's standing at the forefront of advanced health technology and cutting-edge medical devices.”

The InvestEU programme provides the EU with long-term funding by leveraging private and public funds in support of EU policy priorities. As part of the programme, the InvestEU Fund is implemented through financial partners who will invest in projects using the EU budget guarantee and thus mobilising at least €372 billion in additional investment. 

A press release is available online.

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending